| Followers | 9889 |
| Posts | 261364 |
| Boards Moderated | 4 |
| Alias Born | 12/27/2006 |
Monday, May 11, 2020 4:10:17 PM
* * $AMRX Video Chart 05-11-2020 * *
Link to Video - click here to watch the technical chart video
Link to Video - click here to watch the technical chart video
Recent AMRX News
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/22/2026 10:24:08 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/22/2026 10:22:26 AM
- Kashiv BioSciences Agrees to Be Acquired by Amneal Pharmaceuticals to Create a Fully Integrated Global Biosimilar Leader • Business Wire • 04/22/2026 10:17:00 AM
- Amneal Agrees to Acquire Kashiv BioSciences to Create Global Biosimilar Leader; Reports Strong Preliminary First Quarter 2026 Financial Results and Raises FY2026 Standalone Guidance • GlobeNewswire Inc. • 04/22/2026 10:00:00 AM
- Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY® • GlobeNewswire Inc. • 04/20/2026 12:00:00 PM
- Amneal Launches First Two Respiratory Metered-Dose Inhalation Products in the U.S. • GlobeNewswire Inc. • 04/14/2026 12:00:00 PM
- Amneal Launches Bimatoprost Ophthalmic Solution, 0.01% • GlobeNewswire Inc. • 04/09/2026 12:00:00 PM
- Amneal to Report First Quarter 2026 Results on May 1, 2026 • GlobeNewswire Inc. • 04/07/2026 08:01:00 PM
- Amneal Announces $2 Million Donation to Support Patient Access to Essential Medicines During Parkinson’s Awareness Month • GlobeNewswire Inc. • 04/07/2026 12:00:00 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 03/27/2026 08:20:46 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/25/2026 08:16:09 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/25/2026 08:15:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:52:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:51:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:32:25 PM
- Amneal to Participate in Upcoming Investor Conference • GlobeNewswire Inc. • 03/05/2026 09:05:00 PM
- Amneal Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 02/27/2026 11:00:00 AM
- Accessible Health Platforms Gain Scale Across $6T Health and Wellness Market • PR Newswire (US) • 02/13/2026 04:26:00 PM
- Accessible Health Platforms Gain Scale Across $6T Health and Wellness Market • PR Newswire (Canada) • 02/13/2026 04:26:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/28/2026 09:16:01 PM
- Amneal Pharmaceuticals Added to S&P SmallCap 600® Index • GlobeNewswire Inc. • 01/28/2026 09:05:00 PM
- TTM Technologies, Dutch Bros, Advanced Energy Industries, and American Healthcare REIT Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600 • PR Newswire (US) • 01/27/2026 11:02:00 PM
- Amneal to Report Fourth Quarter and Full Year 2025 Results on February 27, 2026 • GlobeNewswire Inc. • 01/27/2026 01:00:00 PM
